Amphastar Pharmaceuticals (AMPH) Change in Intangibles (2017 - 2018)

Amphastar Pharmaceuticals' (AMPH) quarterly Change in Intangibles came in at $4.4 million in Q1 2018, up 340.0% year-on-year from $1000000.0 in Q1 2017, and up 340.0% quarter-over-quarter from $1.0 million in Q3 2017.

Amphastar Pharmaceuticals (AMPH) Change in Intangibles (2017 - 2018) Analysis & Trends

Amphastar Pharmaceuticals' Change in Intangibles history runs 2 years deep, the most recent figure standing at $4.4 million for Q1 2018.

  • On a quarterly basis, Change in Intangibles rose 340.0% year-over-year to $4.4 million in Q1 2018; TTM through Dec 2018 was $4.4 million, a 46.67% increase from a year earlier, with the FY2018 full-year figure at $4.4 million, up 120.0% from the prior year.
  • Change in Intangibles improved to $4.4 million in Q1 2018 per AMPH's latest filing, from $1.0 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at $4.4 million in Q1 2018 and bottomed at $1.0 million in Q1 2017.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -107.94 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Amphastar Pharmaceuticals 855.23 Mn 684.09 Mn 70.32 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2018 4.40 Mn
Mar 31, 2018 4.40 Mn
Sep 30, 2017 1.00 Mn
Sep 30, 2017 1.00 Mn
Jun 30, 2017 1.00 Mn
Jun 30, 2017 1.00 Mn
Mar 31, 2017 1.00 Mn
Mar 31, 2017 1.00 Mn